PathMaker Neurosystems Inc. ('PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
The global food allergy market is estimated at USD 44.1 billion in 2025 and is projected to reach USD 73.2 billion by 2035, expanding at a 5.2% CAGR over the forecast period, according to the latest ...
There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug, with ...
A bipartisan team of U.S. lawmakers has reintroduced the ALS Better Care Act, aimed at improving access to quality medical ...
The Trump administration on Thursday launched TrumpRx, a website it says will help patients buy prescription drugs directly ...
Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral aldosterone-producing adenomas compared with adrenal vein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results